Moleculin Biotech Inc (NASDAQ:MBRX)

3.93
Delayed Data
As of Jun 14
 +0.07 / +1.81%
Today’s Change
3.12
Today|||52-Week Range
9.30
-17.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.006.2K18.0K68.0K
 
 
 
 
 
Operating ExpensesGross Income0.00-6.2K-18.0K-68.0K
 
 
 
 
General Expenses738.2K3.9M8.6M15.0M
 
 
 
 
 
Research And Development260.4K1.5M4.5M9.7M
 
 
 
 
 
Total Operating Expenses738.2K3.9M8.7M15.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-738.2K-3.9M-8.7M-15.0M
 
 
 
 
 
Extraordinary Credit0.000.00149.0K3.2M
 
 
 
Extraordinary Charge0.000.00-2.5M0.00
 
 
Interest Expense On Debt10.1K43.2K----
 
 
 
Other Expenses0.000.001.2M-40.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-748.4K-3.9M-9.8M-11.9M
 
 
 
 
 
Net Income-748.4K-3.9M-9.8M-11.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.3M9.8M18.6M25.9M
 
 
 
 
 
Shares To Calculate EPS Diluted14.3M9.8M18.6M25.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.40-$0.53-$0.46
 
 
 
 
 
EPS Diluted-$0.05-$0.40-$0.53-$0.46